Advertisement
Journal Home
Search for

Volume 48, Issue 1, Pages 92-106 (January 2003)


View previous. 7 of 9 View next.

Motion Perception in Glaucoma Patients: A Review

Noor Shabana, DOMSCorresponding Author Information12, Valérie Cornilleau Pérès, PhD23, Andrew Carkeet, PhD2, Paul T.K Chew, FRCSE1

Abstract 

Most of the histopathological and psychophysical studies in glaucoma reveal a preferential damage to the magnocellular (M) pathway although a few of them support a damage to the parvocellular (P) pathway as well. In glaucoma, the visual fields are usually evaluated by conventional perimetry. However, it has been demonstrated that 20–40% of ganglion cells are lost before field defects are detected using conventional perimetry. Therefore, new psychophysical tests have recently been designed in order to specifically isolate and evaluate the visual mechanisms that are impaired at the early stages of glaucoma. In this context, several authors have addressed the issue of motion perception under the hypothesis of a predominant damage of the M pathway in glaucoma, and that motion perception is mediated mainly by M pathway. The results of these studies depict a large variation in the percentage of patients showing anomalous motion perception. Overall, motion thresholds are elevated in both glaucoma and ocular hypertensive patients as compared to control subjects, irrespective of the stimulus size and eccentricity. The test which discriminates best between patients and normal subjects is motion perimetry. The visual field defects in glaucoma patients identified by conventional perimetry and motion perimetry are similar, but the sizes of the defects are usually larger with motion perimetry. However, motion tests in central vision have no correlation with visual field defect on conventional perimetry. In glaucoma, loss of performance on motion perception tests does not necessarily support the existence of a specific deficit in the M pathway, because some behavioral studies suggest that the P pathway can also mediate motion perception. It is also difficult to conclude that motion perception is specifically affected in glaucoma because most of these studies do not yield a comparison with other visual functions. Despite these difficulties, localized motion perception tests at eccentricities of more than 15° can be considered as a promising diagnostic tool.

Article Outline

Abstract

Visual Pathways

Magnocellular and parvocellular subcortical visual pathways

Dorsal and ventral cortical visual pathways

Histopathological Studies in Glaucoma

M cell loss

P cell loss

Ganglion cell distribution

Interpreting histopathological studies

Psychophysical Studies of Glaucoma

Current clinical glaucoma psychophysics

Studies targeting the m or p pathway

Studies Targeting the M Pathway

Studies Targeting the P Pathway

Studies Targeting M and P Pathways

Review of Motion Perception Studies

Methods

Displacement Thresholds

Coherent Motion Studies: Global Tests

Coherent Motion Studies: Perimetry

Discussion of the studies on motion perception

Discussion

Conclusion

Method of Literature Search

Acknowledgment

References

Copyright

In the last decade, researchers have investigated and developed tests for evaluating damage to motion vision in glaucoma. This research emphasis is motivated by a number of factors. First, there is histological evidence dating from the 1980s that glaucoma preferentially damages the types of ganglion cells that supply motion vision pathways in the brain. Second, there is an interest in developing psychophysical procedures that can be used to detect glaucoma at an early stage of the disease, when less visual function has been lost and when the disease is more amenable to treatment. Third, there has been increasing general interest in motion vision as one of the cardinal aspects of vision, that is, on a par with color perception, brightness perception, and so on. Fourth, if glaucoma does affect motion vision, then it can result in significant behavioral deficits, because motion perception is critical for tasks like judging self-motion, maintaining posture, and navigating in the environment.

Demonstrating the selectivity of glaucomatous damage in terms of anatomy and physiology is a challenge that has led to sustained debate in the literature. First, the histological evidence of selective damage to a sub-population of ganglion cells (magnocellular [M] cells) is persuasive, but not completely conclusive. Second, the correspondence between motion perception and the M pathway is also a disputed matter. Finally, even if glaucoma induced a deficit in a function such as motion perception, and not in other visual functions, it does not demonstrate fully that this deficit is selective for the visual pathway mediating this function. Indeed, different neuronal subpopulations may have different degrees of redundancy, depending, for example, on the amount of overlapping of the receptive field of visual neurons. As noted by Johnson,47 the degree of the functional deficit due to the damage of a neuronal population may hardly be measurable if the redundancy is high.

Thus, we review here these issues and some of their clinical consequences. Initially we provide a brief overview of the anatomy and physiology of the visual pathways. Then we discuss the histopathological studies of primate and human glaucoma, and the nature of ganglion cell loss in glaucoma. We also summarize the results of conventional and non-conventional psychophysical tests in glaucoma, focusing further on the tests that purport to isolate motion-related visual functions. Finally we address the limitations of the previous research and suggest future avenues of glaucoma motion vision research.

All the research presented here was conducted on primary open-angle glaucoma (POAG). One reason is that POAG is more commonly found in western countries than primary angle-closure glaucoma (PACG). Another reason is that PACG is difficult to produce in animal experiments. However, it should be noted that the high prevalence of PACG in Asia calls for an urgent need to study the neural visual correlates of this pathology.

Visual Pathways 

return to Article Outline

Magnocellular and parvocellular subcortical visual pathways 

The primate retina contains 20 or more different types of ganglion cells.55 The in vitro preparation of primate retina shows three types of ganglion cells that project to the lateral geniculate nucleus (LGN): the parasol (Pα), midget (Pβ), and small bistratified cells.16, 77 The morphology, physiology, and central projections of these cells have been well studied in primate retina.20, 111, 112 The parasol ganglion cells have a larger dendritic field and cell body size than the midget ganglion cells at any given eccentricity. The small bistratified ganglion cells tend to have larger dendritic field diameters than the midget cells and smaller than the parasol cells.112 For all cells, the retinal ganglion cell size correlates with the axon diameter and eccentricity.77, 78

Perry et al78 used retrograde horseradish peroxidase (HRP) labeling to illustrate that the large majority of Pα cells in the retina project to the magnocellular layers of the LGN, whereas the large majority of Pβ cells in the retina project to the parvocellular layers of the LGN. Thus, it has become a common practice to refer to the retinal ganglion cells by their putative connections to the LGN, namely, parasol cells as magnocellular (M) cells and midget cells as parvocellular (P) cells.2, 39, 74 For the sake of consistency we will adopt this practice and refer to the parasol and midget ganglion cells as M and P cells, respectively, although we note that it is possible that not all parasol cells and midget cells make these connections.

There is some evidence that a third class of cells, the small bistratified cells,18, 19 project to the koniocellular (K) layers of the LGN, in parallel with the parasol and midget cells.18, 66 The bottom part of Fig. 1 summarizes the current view of ganglion cell projections to the LGN. This picture should not be considered complete, because the details of most other ganglion cell type are still not known.


View full-size image.

Fig. 1. A simplified view of visual pathways presented in a schematic form from retinal ganglion cells to the higher levels of cerebral cortex. The projection of the M cells in the retina to the M layers of the LGN forms the magnocellular pathway and similarly the projection of P cells in the retina to the P layers of the LGN forms the parvocellular pathway. The axons of the magnocellular and parvocellular layers of LGN project to 4Cα and 4Cβ of the primary visual cortex. Recently recognised small bistratified cells project to koniocellular layers of LGN. The dorsal (parietal) visual pathway proceeds from primary visual cortex and end in the parietal cortex and the ventral (temporal) visual pathway also proceeds from the primary visual cortex and ends in the temporal cortex. Note that inspite of an early segregation of the M and P projections, the parietal and temporal pathways present complex pattern of connections. M Cells (magnocellular ganglion cells); P Cells (parvocellular ganglion cells); LGN (lateral geniculate nucleus); Magno (magnocellular layer); Parvo (parvocellular layers); Konio (koniocellular layers); V1 (primary or striate visual cortex); V2, V4 and MT (middle temporal area) are cortical (extra striate) areas. (Modified from Merigan and Maunsel.72)


There are considerable differences in the physiological properties of the two pathways. The M cells have higher contrast sensitivity than P cells.52, 79 The conduction velocity of the M pathway is faster than the P pathway.30, 65, 96 The time course of the response in the M pathway tends to be transient, whereas it is more sustained in the P pathway.23, 45, 96 The M cells are sensitive to high temporal and low spatial frequency stimuli, and P cells are sensitive to low temporal and high spatial frequencies.24, 45 The M pathway responds to broad-band light of different wavelength, whereas the P pathway mediates visual acuity71 and color.24, 69, 94 Recent research indicates that blue-yellow color is mediated by the small-bistratified ganglion cells and red-green color by the P ganglion cells.17

This functional segregation between the M and P pathways has been illustrated by behavioral studies of monkeys with ablated sections of LGN. Schiller et al showed that lesions of the P layers resulted in marked decreases in spatial contrast sensitivity; fine stereopsis; and pattern, color, texture, and shape discrimination.94, 95 These functions were unaffected by lesions of the M layers. In comparison, lesions of the M layers caused specific decreases in flicker (especially at high temporal frequencies) and motion sensitivity. Interestingly, low spatial frequency stereopsis, brightness discrimination and some aspects of shape discrimination were unaffected by either P or M lesions, but they were lost if both types of layers were lesioned, suggesting that these functions were carried by both M and P layers. Another study68 showed that M lesions resulted in a reduced sensitivity to high temporal frequency contrast flicker, but that the critical fusion frequency and contrast sensitivity for low temporal frequency and moderate spatial frequency stimuli were unaffected by such lesions.

Dorsal and ventral cortical visual pathways 

The axons from the M layers of the LGN project to the lamina 4C-α of the primary (striate) visual cortex (V1), while the axons from P layers project to layer 4C-β.78 Thus, the M and P visual pathways from the retina to the LGN remain clearly separated up to the level of V1. Subsequently, at the level of cortical processing, the segregation is only partial.72 However, two pathways dominate the complex network of connections in the visual cortex: the dorsal and ventral visual pathways (Fig. 1).105, 106 The dorsal visual pathway proceeds from V1 via the thick stripe regions of V2, mainly to the middle temporal (MT) area (specialized in motion processing) and to areas in the posterior parietal cortex. It receives a major contribution from the M pathway.72 The ventral visual pathway proceeds from V1, via the thin and interstripe regions of V2, mainly to V4 (specialized in color processing) and to areas of the inferotemporal (IT) cortex. It receives a major contribution from the P pathway.

The dorsal visual pathway plays a prominent role in motion perception, spatial localization and sensory motor coordination,40 whereas the ventral visual pathway is involved in the visual identification of colors, patterns, or objects.105

In spite of this gross functional specialization, the dorsal and ventral visual pathways should not be considered as a simple prolongation of the M and P subcortical streams. For instance, there is evidence of a moderate P input to cortical area MT.68 In addition, some aspects of visual motion perception are unaffected by M lesions of the LGN.70

Fig. 1 summarizes the main current knowledge about the neural transmission in the visual system. The dorsal and ventral pathways are grossly parallel, but there are over 300 known connections between them.72 A simplified view of the dorsal and ventral cortical visual pathways of the rhesus monkey is shown in Fig. 2.


View full-size image.

Fig. 2. Schematic representation of the dorsal and ventral cortical visual pathways showing simplified view of the left hemisphere of a rhesus monkey. The dorsal pathway starts from the occipital lobe (OL) and ends in the inferior parietal lobe (IPL) and ventral pathway starts from OL and ends in the infertemporal cortex (IT). The positions of primary visual cortex (VI), middle temporal lobe (MT), IPL located within posterior parietal cortex are roughly indicated.


In summary, the two major subcortical visual pathways (M and P), which proceed from the respective ganglion cells, show a clear segregation up to the LGN. Subsequently, the mapping of the subcortical to the cortical (dorsal and ventral) visual pathways is not one-to-one as there is mixing of the M and P streams within the visual cortex.25

Histopathological Studies in Glaucoma 

return to Article Outline

The consequences of monkey or human chronic glaucoma on the visual pathways have been extensively studied at the levels of the retina and LGN. Early anatomical studies indicate that large retinal ganglion cells are more susceptible to glaucomatous damage than small cells, but this idea has been recently contradicted. Here we review the arguments related to this issue.

M cell loss 

Immunolabelling for calcium binding and neurofilament (NF) proteins conducted on retinal tissue of monkey showed no significant differences between the amacrine, horizontal, and bipolar cells in glaucomatous and normal eyes. However, retinal ganglion cells defined by their content of NF proteins, many of which were likely to correspond to M ganglion cells, were greatly reduced in number in glaucomatous eyes as compared to normal eyes.108

Glovinsky et al compared 32 temporal midperipheral retinal locations in 4 monkeys with monocular glaucoma with the normal fellow eye.39 They demonstrated that the distribution of ganglion cell sizes of upper and lower retinal areas were similar. However, more large ganglion cells were lost in the lower than in the upper retina. The optic nerve zones corresponding to these retinal areas also showed a loss of large diameter axons. Quigley et al induced chronic glaucoma in one eye of 10 monkeys (Macaca fascicularis), whose retinal and optic nerve anatomy is close to that of humans.85 They compared the glaucomatous eye to the normal fellow eye, dividing each optic nerve into 16 equal sections. Regardless of the location in the optic nerve, there was a preferential loss of axons of large diameter, which suggests that large ganglion cells are preferentially lost, because ganglion cell size correlates with axon size.77, 78 Similarly, in 7 monkey eyes with chronic intraocular pressure (IOP) elevation, Dandona et al demonstrated that the M layers of the LGN showed less transport of radioactive substance than the P layers.21 In the eyes with normal IOP, the labeling of the M layers was equal or slightly heavier than in the P layers.

In human eyes, a comparison of the size and number of retinal ganglion cells in 6 post-mortem eyes with glaucoma and 5 age-matched post-enucleated normal eyes showed fewer remaining large ganglion cells in the retinal area with atrophy in glaucomatous eyes.83 Also, in a post-mortem comparative study of glaucomatous and normal eyes, the optic nerve fibers larger than the mean diameter were lost earlier than the smaller fibers.84 The loss was spread throughout the nerve, but it was 2 to 3 times more in the vertical poles. LGN autopsy sections of individuals with and without glaucoma showed that the density of M cells was significantly smaller in the glaucoma group than in the control group. No such effect was measured in the P layers.13

Chronic experimental glaucoma in monkeys is similar to chronic human glaucoma, both clinically and histopathologically.89 Therefore, there is a general agreement between monkey and human studies for a preferential damage to large ganglion cells, and the cause of ganglion cell death is commonly attributed to the elevated IOP. The damage to optic nerve fibers in chronic glaucoma tends to respect the following rules. First, at a given location within the optic nerve head, large fibers are lost at a relatively higher proportion than small fibers, because they are more sensitive to the elevated IOP.39 Second, the degree of fiber loss varies as a function of the position within the optic nerve head. Nerve fibers in the superior and inferior poles of the optic nerve typically exhibit the greatest susceptibility to glaucomatous damage.84 It is not clear why large fibers are sensitive to elevated pressures. It could be due to the fact that they are found mainly in the weaker part of the optic nerve head, which corresponds to the superior and inferior poles. Indeed the connective tissue and glial cell structures are thinner in this area as compared to the nasal and temporal areas.81, 87, 88 However, in a recent study, Radius has suggested as an alternate theory, that in eyes with elevated pressure the absorption of nutrients from the axon membrane is decreased due to decreased tissue perfusion.86 This would affect the normal functioning of large fibers more so because of their larger surface-to-volume ratio.

P cell loss 

Although there seems to be an agreement on the predominant loss of large fibers in chronic glaucoma, it should be emphasized that retinal ganglion cells with large axons are not necessarily M cells.47, 84, 99 M cells constitute only about 10% of the ganglion cell population.78 Therefore, some large P cells could also be included among the large cells that are lost.39 Indeed, a reduction in the proportion of P and M cells in the monkey LGN has been demonstrated in cases of chronic glaucoma.99, 107, 114 As far as acute glaucoma is concerned, one monkey eye with acute IOP elevation showed less radioactive labeling in the P layers, as compared to the M layers of the LGN.21 Therefore, both chronic and acute glaucoma preparations have also provided evidence for P losses in the LGN.

In cats, large (Y) ganglion cells are more tolerant to acute IOP elevation than small (X) cells.43, 97 This could be due to the fact that Y cells tend to have more intracellular reserves of ATP, oxygen, and potassium than X cells during ischemia produced by brief elevation of IOP.42, 58 Particular care should be taken, however, when comparing cat and human ganglion cells. Cat X and Y cells share similarities with primate Pβ and Pα cells, respectively (e.g., in terms of relative soma size, relative axon size, relative conduction velocities, and relative transience of response). However, at the level of LGN, very few primate M cells (6–25%) show the marked non-linearity of response that cat Y-ganglion cells do,7 and some primate P cells (0.6–0.7%) have Y-like response characteristics.24, 52

Ganglion cell distribution 

The fact that the glaucomatous damage starts in the mid-peripheral retina is also compatible with a predominant loss of large fibers.39 Indeed, retinal ganglion cells located near the fovea have small cell bodies and comparatively small axons because ganglion cell size increases with eccentricity for both M cell and P cells.111

Interpreting histopathological studies 

The studies reviewed here do not conclusively demonstrate the specificity of M cell losses in glaucoma. Resolving the discrepancies of the results is difficult for several reasons. First, most human histological data come from eyes that are obtained after post-mortem or enucleation.83 Such tissue may not be identical to that obtained from otherwise healthy glaucoma patients. Second, although similar techniques are used to elevate IOP in all studies, the duration and level of IOP elevation may play a role in the type of ganglion cells that are affected.39, 43, 99 Third, the methodologies used so far are by their nature cross-sectional and cannot evaluate the relative progresses in the loss of different cell types.

Despite these difficulties, we can conclude that most of the histopathological studies suggest that the neural loss in glaucoma is partially selective for the M pathway, although the P pathway is not spared. The losses also seem to affect mainly the large cells, which is consistent with greater losses at the peripheral retina where ganglion cells have larger cell bodies and axon diameter than in the fovea.

In spite of this evidence, we should be cautious at predicting that there will be a selective loss in functions subserved by the M pathway, such as motion perception. Indeed, the hypothesis of reduced redundancy47 states that the observed functional deficits will also depend on the degree of redundancy present in the different cell populations subserving different functions.

Psychophysical Studies of Glaucoma 

return to Article Outline

Current clinical glaucoma psychophysics 

A major principle of current clinical glaucoma assessment is the testing of different points of the visual field, in a search for patterns of field loss that are considered typical of glaucoma. Modern differential light-sensitive (DLS) automated perimetry for visual field testing has historical origins in manual perimetry, and it has not been specifically constructed to test the M or P pathways.

In DLS automated perimetry, the patient looks into a white hemispherical bowl, at a small fixation target with the head is stabilized. The stimulus is usually a broadband visible light of constant size but of variable luminance. It is briefly presented (0.1–0.2 sec) on a uniform background of white light at different eccentricities. The minimum luminance required to detect the stimulus at each location is determined. Estimation of reliability factors such as fixation losses, false-positive, and false-negative responses are considered before interpretation of the visual fields. Different commercial varieties of DLS perimeters (e.g., Octopus, Humphrey Field Analyser (HFA), Dicon, etc.) are available. In the following paragraphs, we have kept the term HFA wherever the original authors have used it.

In glaucoma, visual field testing is usually conducted with the Goldman size III target (0.43°). This stimulus seems to detect advanced rather than mild visual field changes in humans44 because the autopsy of human glaucomatous eyes shows 20–40% of ganglion cell losses before field defects are detected with DLS perimetry.82, 83 In addition, the achromatic stimuli (white light on a white background) that are typically used in DLS automated perimetry have been reported to be nonspecific in their stimulation of various types of ganglion cells.15, 95 Therefore, DLS perimetry may not detect the earliest functional losses, and the goal of new psychophysical tests is to specifically evidence early pathological changes of the visual system in glaucoma.

Studies targeting the m or p pathway 

Based on the anatomical and functional data above, many studies have explored the psychophysical correlates of glaucoma-induced deficits in visual perception. In most of them, the visual functions are evaluated by targeting either the M or P pathway, but some have targeted both pathways in the same patients. Their purpose is to reveal visual functions that are impaired in glaucoma, reveal selective versus non-selective losses in glaucoma, and search for diagnostic tools for glaucoma.

Studies Targeting the M Pathway 

Frequency-doubling perimetry (FDP),12, 50, 63, 80, 100 pattern-discrimination perimetry,31, 32 and scotopic sensitivity38, 101 are some of the tests introduced to target the M pathway. FDP is briefly described here, as some investigators believe that it can be used as a diagnostic12, 22, 63, 100 and a screening50, 80, 113 tool for glaucoma. The stimulus is a large (10 × 10°) low-spatial frequency sinusoidal grating (0.25 c/°) consisting of black and white bars undergoing a rapid counter phase flicker (25 Hz). In the normal eye at a certain level of contrast, the spatial frequency appears to double (the frequency doubling illusion).54 Glaucoma patients fail to detect the FDP stimulus in regions that match grossly the part of the visual field that is found defective through DLS perimetry.80, 100 It has been argued that the failure to detect the FDP stimulus could be due to a loss of My cells (a subset of M cells) in glaucoma.53, 62 However, this is still strongly debated, as some authors report the responses of glaucoma patients might not be due to a doubling illusion effect, but rather to a change in contrast or an apparent flicker of the stimulus.103, 104 Also, the isolation of My cells by the FDP test remains to be clearly determined.24, 57

Studies Targeting the P Pathway 

Short-wavelength automated perimetry (SWAP)37, 48, 92 and high-pass resolution perimetry (HRP)6, 14, 36, 67 have been used to target the P pathway. It has been reported that SWAP detects earlier48 and more extensive92 visual field defects than HFA. Previously it was considered that SWAP involves the P pathway, but now it is thought that SWAP isolates the blue cone pathway via the small bi-stratified sub-population of ganglion cells. Whether the axons of these ganglion cells project to the K cell interlaminar layers of LGN is still under study, but there is some evidence for this.66

Studies Targeting M and P Pathways 

Bassi et al5 studied contrast sensitivity, stereoacuity, and color vision in glaucoma patients and concluded that the results reflect a selective damage to the M pathway by referring to the functional properties of this pathway.59, 60 However, this conclusion is questioned as stereopsis may also be mediated by the P pathway95 and deficits in color perception have been reported by others in glaucoma.28, 93 Peripheral resolution acuity measurements using gratings that were either stationary or dynamic (phase reversed at 30 Hz) revealed that dynamic resolution was significantly more affected than static resolution, suggesting a dominant M function loss in glaucoma.2 In another study, a battery of psychophysical and electrophysiological tests reflect glaucomatous damage to a varying degree, and do not point to a specific M or P loss.41

In glaucoma patients and suspects, a comparison of motion-automated perimetry (MAP) (see below for a thorough description) and SWAP was performed in one study,91 and in a second study90 MAP, SWAP, FDP, and HFA were compared. In both studies, each test successfully identified a subset of eyes as abnormal. In the latter study, many more OHT subjects (17 of 37) gave abnormal results with FDP as compared with the results of HFA (2 of 37). These OHT subjects were selected without reference to the results of the HFA. The percentage of OHT subjects, which show abnormal results on FDP, was much higher than those which might be expected to convert to glaucoma. Therefore, it suggests that FDP is not a selective screening tool but may be useful in combination with other perimetry tests. Because SWAP, FDP, and MAP are very likely to stimulate different types of ganglion cells, these studies support non-specific ganglion cell loss. As suggested by Sample et al,91 it could also be that individual differences exist in the type of ganglion cells that are first affected in glaucoma.

In conclusion, psychophysical studies reveal an early selective loss in glaucoma either by targeting the M or the P pathways. However, most of the studies which compare the integrity of these pathways in the same group of patients reveal that visual functions subserved by both the M and P pathways are affected5, 41, 90 and that the tests targeting the M pathway seem to be more sensitive for detecting glaucoma.2, 91

Review of Motion Perception Studies 

return to Article Outline

A number of studies have tested the hypothesis that an impairment in motion perception could occur early in glaucoma, possibly before any field loss could be observed with conventional perimetry.

Methods 

The tests of motion perception include global (full field) and local (at eccentricities) motion tests. The most commonly used stimuli are dynamic sparse random dots generated on a computer screen. Such stimuli are of methodological interest in ophthalmology, because the motion sensitivity seems relatively immune to blur variations for these stimuli. Indeed an optical blur of 3.25 diopters (D) does not modify coherent motion thresholds for a range of stimulus displacement and speed,4 and up to 8 D of optical blur weakly modified motion thresholds for a range of contrast values.102 Such stimuli are used to measure 1) the minimum and the maximum perceived displacements, referred as Dmin and Dmax, respectively, (Fig. 3); and 2) the ability to report or detect the motion of a subset of coherently moving dots, within a population of randomly moving dots. The corresponding percentage of coherently moving dots (PCD) ranges between 0% and 100%, and it produces graded intensities of motion signal (Fig. 4). PCD stimuli can be presented either globally or in small regions of the visual field in perimetry tests (Fig. 5).


View full-size image.

Fig. 3. The minimum perceived displacement within a random dot kinematogram is called Dmin and the maximum perceived displacement is called Dmax.



View full-size image.

Fig. 4. Random dot kinematograms are used to study global motion perception. A: All dots move in random directions, hence no coherent motion is perceived. B: 50% of the dots move in the same direction, in a coherent motion.



View full-size image.

Fig. 5. Diagram of motion perimetry. The enlarged target shows 50% of the dots moving at random and 50% moving in one direction (bold dots). X = the fixation target. (Redrawn from Wall et al.110)


The different psychophysical tasks are direction discrimination (indicating the motion direction), motion detection, and motion localization (pointing to the area of movement).

Displacement Thresholds 

Dmin and Dmax thresholds in central vision have been measured over a 2.9° or 19° field of vision in a glaucoma and OHT patients.10 The results reveal a larger impairment in motion sensitivity in glaucoma patients for Dmin, as compared to Dmax. However, the Dmin values were poorly correlated with the visual fields on HFA. Bullimore et al interpret their results as the consequence of a preferential damage to the larger M ganglion cells.10 This is in agreement with the fact that magnocellular cells are more sensitive to small displacements than P cells.56

In another study, peripheral displacement threshold was measured at 15° in the temporal field just above and below the blind spot.35 The target was a 2° by 2° vertical line oscillating at 2.5 Hz. Thresholds were measured as the minimum amplitude of oscillation that could be detected. A general increase of displacement thresholds occurred in glaucoma and OHT patients. However, as noted elsewhere,10 the histograms suggest that the peripheral displacement thresholds were elevated in only 9 of 16 (56%) glaucoma patients and in 10 of 45 (22%) OHT subjects.

Coherent Motion Studies: Global Tests 

In several studies, coherent motion thresholds in central vision were measured in normals, and glaucoma and OHT patients. Motion thresholds for a large stimulus (60° width), with low (0.03 dots/degree2) dot density, fell significantly outside the normal range for POAG and OHT patients.98 However, there was a considerable overlap in performance between patients and normal subjects. Because the results did not correlate with the HFA test, the authors suggest that the deficits in motion perception might occur early in the pathology.

Global testing with PCD also showed a poor discriminatory power between POAG and normal subjects in two other studies. First, with a 19° stimulus, and dot density of 7 dots/degree2 no significant difference in motion thresholds between patients and normal subjects was found.10 Second, the same result was obtained with a 25.1° stimulus and a dot density of 0.83 dot/degree2.9

Contrasting with these results, when a 24.5° stimulus with a density of 0.42 dots/degree2 was examined, a significant elevation of the coherent motion thresholds was observed in 70.6% of POAG patients.102 The deficits were more frequently detected with a speed of 12.5°/second, rather than a speed of 4.2°/second. In addition, there was a significant correlation between HFA visual defects and motion thresholds for high speeds, but not for low speeds. Motion deficits were detected in OHT patients, but they were not significant.

In this latter study, a possible reason for the difference in the results of the two speeds is that fast motion tends to be coded by the M pathway, while slow motion may involve the P pathway.70 However, the results obtained by Trick et al102 contradict the lack of difference between glaucoma patients and controls found by Bosworth et al,9 as described above. The major difference between the two studies is that Trick et al102 used a contrast (15.6% for the highest velocity) that was half that used by Bosworth et al.9 Considering the fact that the M pathway is sensitive to low contrast, a possible explanation is that the stimuli used in the study by Trick et al targeted more specifically the M pathway and led to a better glaucoma discriminatory power for their test.

In any case, the best sensitivity observed across different stimuli in the study of Trick et al is 70.6% for glaucoma patients. Therefore, it can be concluded that global testing through PCD is not an adequate tool for glaucoma screening and diagnosis. This could be due to the fact that global stimuli address both pathological and normal regions, which limits their discriminatory power for glaucoma.46 Also, a centrally placed stimulus would fail to cover the damaged visual areas in many early glaucoma patients.51

Coherent Motion Studies: Perimetry 

Because of the poor sensitivity of global motion testing, several authors designed perimetric motion tests, which have the double benefits of testing motion perception and isolating areas that are affected by glaucoma.

A first study by Bosworth et al showed that the regions of visual loss, as defined by the HFA visual fields, had a significant lower threshold for coherent motion than the regions that were relatively spared by the disease.8 This study gave some methodological support (in terms of the sensitivity of the test) to the use of restricted size stimuli (here 7.3° wide) to map motion sensitivity in different regions of the glaucomatous retina.

A motion perimetry study was performed by Wall and colleagues, who used targets of 20 different sizes (0.25–21°).110 The size of the target varied from trial to trial, and a 2-1 staircase procedure was used. These targets were randomly presented at 44 visual field locations within the 54 locations of the 24-2 HFA test (some of the most eccentric points were skipped). The target was a field of static dots, within which a circular area of moving dots was shown. In this area, 50% of the dots moved coherently, at 30°/second. The target size was decreased, until the smallest motion target could be localized. The POAG patients showed a significant increase of the motion size thresholds, as compared to controls, in many loci of the visual field. The loci expanded over most of the defects revealed by HFA, but they were usually larger than the defects. In addition, motion perimetry identified defects following nerve fiber bundle-like patterns, which were missed by the HFA.

The same procedure showed that OHT patients had slightly higher motion-size thresholds than controls.109 Although on average the difference was not significant, 6 OHT patients presented field defects following a nerve fiber bundle-like pattern. Therefore, motion perimetry used by Wall et al seems to be highly effective in glaucoma screening and in diagnosing OHT subjects.109, 110

Using a fixed target size of 3 degrees, Joffe and colleagues tested each quarter of the visual field along the horizontal, vertical, and oblique meridians (Fig. 6A).46 The target was presented at 22 locations, including the fovea and eccentricities of 9°, 15°, and 21°. The dot speed was 2.63°/second. The subject's task was to indicate the direction of coherent motion. The PCD was decreased from 100%, until the motion direction was wrongly reported. Under foveal testing, no significant difference was found between glaucoma patients and controls. However, the mean peripheral thresholds (at 21° eccentricity) were significantly different between the glaucoma and control groups. This difference was the largest in the superior visual field (SVF) (Fig. 6B), but the four quadrants of the visual field of glaucoma patients presented a decrease in motion sensitivity. As for glaucoma suspects, the deficits occurred only in the SVF. Overall, significant SVF deficits occurred in 10 of 12 patients, and in 8 of 15 suspects, and the deficits tended to increase with eccentricity.


View full-size image.

Fig. 6. A: Stimulus location at various eccentricities. Along the horizontal axis, negative numbers indicate normal hemifield locations and positive numbers indicate temporal hemifield locations. B: Group mean motion sensitivity as a function of eccentricity along the sup vertical meridian for each group. Both patient group exhibit lower sensitivity than controls at all eccentricities with greatest deficit at most eccentric location. (Fig. 6A was redrawn and Fig. 6B was reprinted from Joffe et al46 with permission of Vision Research.)


A similar procedure was conducted by Bosworth et al in which a 7.3° stimulus was presented in 15 locations, including the fovea, and led to similar results (see Table 1, lower 2 rows) for glaucoma patients.9 However, the results of Bosworth et al9 differed from Joffe et al46 in that 1) Bosworth et al do not report the high difference between the upper and the lower visual fields, and 2) more importantly, the percentage of glaucoma suspects found abnormal in the study of Bosworth et al9 is 26%, which is considerably lower than the 53% obtained in the study of Joffe et al.46 There are a number of possible reasons for this inter-study difference in discriminatory power. For example Joffe et al46 used a smaller stimulus of 3°, which might be better at detecting small motion scotomas than the 7.3° stimulus size used in the study by Bosworth et al.9 In addition, the two studies use different criteria for normal controls, with Bosworth et al9 defining normals as having IOP of ≤ 21 mm Hg, cup/disk ratio of < 0.6 and normal HFA 24-2 fields and Joffe et al46 using the definition of IOP < 21, cup/disk ratio < 0.4 and normal HFA 30-2 fields. Hence, it may be possible that more borderline suspects may be detected in the study by Joffe et al.46

Table 1.

Comparison of Several Studies on Motion Perception in Glaucoma

Psychophysical testReferencesStimulus Size (deg)Eccentricity (deg)Speed (deg/s)DiagnosisNo. of Patients% of Patients with Elevated Thresholds
TaskStimulus
Motion detectionDminBullimore et al10 (1993) 2.90OHT POAG23 159% 67%
Motion detectionDmaxBullimore et al10 (1993) 190POAG1513%
Motion detectionLineFitzke et al35 (1987) 2 × 215 (above & below the blind spot)OHT POAG45 1622% 56%
Direction discriminationCoherent motion (global)Bullimore et al10 (1993) 19010POAG1520%
Direction discriminationCoherent motion (global)Silverman et al98 (1990) 600OHT POAG14 3721% 43%
Direction discriminationCoherent motiona (global)Trick et al102 (1995) 24.5 24.50 04.2 12.5OHT POAG OHT POAG16 17 16 1737.5% 58.8% 12.5% 70.6%
Motion localisationCoherent motion (perimetry)Wall et al109 (1997) Wall et al110 (1995) 0.5–212430OHT POAG27 2522% 96%
Direction discriminationCoherent motion (perimetry)Joffe et al46 (1997) 3212.83Glaucoma suspects POAG15 1253% 83%
Direction discriminationCoherent motion (perimetry)Bosworth et al8 (1997) 7.3242.83Glaucoma suspects POAG31 1926% 84%
a

Results taken at 15.6% contrast for cardinal direction analysis.

A separate issue to consider is that, in the study by Joffe et al,46 the 53% of glaucoma suspects giving abnormal results on motion perimetry is a higher percentage than expected and may be overcalling defects, because from clinical practice we know that only a very small percentage of glaucoma suspects convert to glaucoma.73 This percentage is even more unusual given the stringent criteria used in the study by Joffe et al46 for defining glaucoma suspects (IOP of > 21mm Hg, cup/disk of < 0.4 and normal HFA 30-2 fields) compared to the study of Bosworth et al9 (IOP > 24 mm Hg, cup/disk ratio of ≥ 0.6 and normal HFA 24-2 fields). Thus, motion perimetry used in the study by Joffe et al46 appears not to be very selective for potential glaucoma patients and further study is required to explain the large number of suspects found abnormal.

In conclusion, motion perimetry reveals a decrease in motion sensitivity in specific areas of the visual field. All three studies9, 46, 110 found motion perimetry defects in similar areas as the HFA, and detected abnormalities in a proportion of OHT or glaucoma suspects (26%, 53%, and 22%, respectively). These results clearly support the need for larger population testing and also for working out the differences in their chosen experimental parameters.

Discussion of the studies on motion perception 

As summarized in Table 1, there is a large variation in sensitivity across the motion tests. The motion thresholds are elevated in 13–96% of the POAG patients, and 21–53% in OHT or glaucoma suspects.

In addition to the differences in the stimulus parameters such as size, dot density, and presentation time used in the various studies, each study compares patients to different normative databases (visual field examinations were done using different DLS perimeters). Also, considering the database of normal subjects (presenting totally normal visual fields), the question arises whether a given percentage present early glaucoma deficits creating losses that were not detected by DLS perimetry.

The reports on the minimum-displacement thresholds yield similar results,10, 35 with less than 67% of glaucoma patients being considered abnormal. On one hand, the score of 67% abnormal patients found by Bullimore et al10 in central vision suggest a deficit in motion perception occuring prior to HFA detection. On the other hand the 56% score obtained by Fitzke et al35 seems to be very low, considering that the tested regions above and below the blind spot are field areas often affected in early glaucoma.26, 27, 29 This contradiction could either be due to the longer presentation duration (2 seconds) used by Fitzke et al or to the fact that these authors used a line stimulus with a determined shape, which could stimulate the P pathway, whereas Bullimore et al used random-dot motion which could address more specifically the M pathway. Indeed it has been found that line movements and random dot movements have different psychophysical properties in terms of the sensitivity to their temporal and spatial frequencies,75 which is compatible with the idea that the motion of line patterns might also be processed by the P pathway.

Overall, the best sensitivity to glaucoma is obtained in the three studies of motion perimetry.9, 46, 110 The elevated motion thresholds were 83–96% for POAG patients. These rates are higher than those obtained with global motion tests. Also, these tests are designed to assess small localized areas of the visual field. Interestingly, these perimetry studies delineate defects in parts of the visual field that are considered normal with the HFA. In this regard, Joffe et al46 find that the highest deficits occur in the superior hemifield, as is usually found by the HFA. This confirms the fact that the greatest damage to the optic nerve head occurs in the inferior pole,11 and it supports the hypothesis that the arcuate fibers of the superior field are particularly susceptible in early glaucoma.1 However, it contrasts with the finding, that motion deficits occur also in the inferior field for glaucoma patients and suspects.9, 110 In any case, all three studies detected deficits in areas where no defects were detected with HFA, and in most cases the extent of field losses was larger if depicted by motion perimetry. Together with the high rate (53%) of OHT patients found abnormal,46 it suggests that early glaucomatous damage affecting motion perception occurs in these areas.

Finally, the high sensitivity (84%) and specificity (100%) obtained with motion perimetry9 for glaucoma patients are close to the reported sensitivity (87–97%) and specificity (90–99.8%) of FDP.49, 76 However, motion perimetry is only a promising screening tool, as we have seen above that FDP has been validated in studies involving large12, 61, 64 numbers of patients whereas motion perimetry has been tested only on three restricted populations.

Discussion 

return to Article Outline

Histological studies in glaucoma reveal ganglion cell death and support, in part, a predominance of M cell losses. Psychophysical testing demonstrates that glaucoma affects motion sensitivity. Similarly, the results of FDP studies, which do not target motion sensitivity, but the apparent frequency doubling of gratings, suggest that this deficit could occur early in glaucoma, prior to any detection by HFA. However, interpreting the glaucoma motion deficit as due to M cell losses presents some difficulties.

First, the question of a selective M cell loss in glaucoma is still debated. Johnson states that a selective psychophysical test does not reveal loss of a selective pathway until the integrity of the other pathway is tested.47 Therefore, there is a need to develop more comparative psychophysical studies for M and P pathways. Indeed, some of the comparative studies in glaucoma reveal the existence of a deficit in the P pathway.41, 90, 91 Overall, the question of the differential vulnerability of the M and P pathways in glaucoma still remains.

Second, there is some question as to whether the motion tests described above are selective for the M pathway. In most tests the P input should be weak and the fast M cells should be targeted preferentially by the motion stimuli. However, the isolation of M cells can be doubted for several reasons. First, recent monkey studies have demonstrated a moderate P input into the motion area MT68 and a lesion of the M pathway does not impair perception of motion at slow speeds.70 Second, M lesions of the LGN in monkeys do not alter the weak directional selectivity of neurons in cortical area V4.33, 34

Finally, other studies also support the view that the P pathway plays a role in processing motion information.3, 95 Nevertheless, the possibility of a P contribution to motion perception is usually ignored in the motion studies reviewed above. It should be noted that motion testing using faster stimuli is more selective for glaucoma deficits.102 Therefore, some of the motion tests, particularly those at low velocities, may have involved the P pathway. The further development of psychophysical motion tests in glaucoma will therefore require a closer definition of their parameters if they are to demonstrate a specificity of the M cell losses.

Conclusion 

return to Article Outline

Motion perception is impaired in glaucoma and also in OHT patients with normal fields on HFA. Despite a few difficulties in interpreting motion perception tests, motion perimetry9, 46, 110 can be considered as a promising diagnostic tool. However, it has to be repeated on a large number of patients to determine its clinical significance. A longitudinal follow-up is necessary to determine if eyes with OHT and suspected glaucoma with motion perimetry will eventually develop field loss on HFA.

A better understanding of glaucoma-related visual impairment might be reached by considering that glaucoma damages more fibers in the periphery. Therefore, psychophysical studies analyzing the motion perception in large field, possibly excluding the central field, will probably be of high relevance.

Because of the difficulties described above, the results of motion perception studies in glaucoma are not a proof of the specificity or even the dominance of M ganglion losses over P losses. In order to investigate further this question, psychophysical tests will be very useful in the future, because they address the species of interest (humans) under natural conditions (clinical glaucoma). In this regard, they are likely to continue to complement animal or post-mortem studies in a very fruitful way. Our review points towards two directions for research: 1) to develop a motion perimetry test that specifically targets the M pathway, and 2) to compare this new test to a perimetry test specifically targeting the P pathway on the same patients.

Method of Literature Search 

return to Article Outline

An online search of the literature was conducted on Medline, covering all years from 1966 to 2001. Other sources such as ARVO abstracts, INIST-CNRS (France), articles cited in the reference list of other articles, and related books in Clinical Ophthalmology and Visual Pathways were searched. The following search words were used: subcortical and cortical visual pathways, magnocellular loss and glaucoma, parvocellular loss and glaucoma, motion perception and glaucoma, small bi-stratified cells, short wave length automated perimetry, frequency doubling technology perimetry, P pathway, motion perception, and authors' names. All articles on histopathology in glaucoma regarding the ganglion cell loss and psychophysical studies specifically targeting M and P pathways in glaucoma and only relevant articles on visual pathways until the year 2000 were included. All articles included were in English except one English abstract of non-English article.

Acknowledgements 

return to Article Outline

The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

References 

return to Article Outline

1. 1 Airaksinen PJ, Drance SM, Douglas GR, et al.  Diffuse and localized nerve fiber loss in glaucoma. Am J Ophthalmol. 1984;98:566–571. MEDLINE

2. 2 Anderson RS, O'Brien C. Psychophysical evidence for a selective loss of M ganglion cells in glaucoma. Vision Res. 1997;37:1079–1083. MEDLINE | CrossRef

3. 3 Anderson SJ, Willis A. Parvocellular contribution to human motion perception. Invest Ophthalmol Vis Sci. 1996;37(Suppl):S747; [abstract].

4. 4 Barton JJ, Rizzo M, Nawrot M, Simpson T. Optical blur and the perception of global coherent motion in random dot cinematograms. Vision Res. 1996;36:3051–3059. MEDLINE | CrossRef

5. 5 Bassi CJ, Galanis JC. Binocular visual impairment in glaucoma. Ophthalmology. 1991;98:1406–1411. Abstract

6. 6 Birt CM, Malam F. High-pass resolution perimetry versus light sensitivity perimetry in ocular hypertensives (a prospective study of test). Invest Ophthalmol Vis Sci. 2000;37(Suppl):S292; [abstract].

7. 7 Blakemore C, Vital-Durand F. Organization and post-natal development of the monkeys lateral geniculate nucleus. J Physiol. 1986;380:453–491. MEDLINE

8. 8 Bosworth CF, Sample PA, Weinreb RN. Motion perception thresholds in areas of glaucomatous visual field loss. Vision Res. 1997;37:355–364. MEDLINE | CrossRef

9. 9 Bosworth CF, Sample PA, Weinreb RN. Perimetric motion thresholds are elevated in glaucoma suspects and glaucoma patients. Vision Res. 1997;37:1989–1997. MEDLINE | CrossRef

10. 10 Bullimore MA, Wood JM, Swenson K. Motion perception in glaucoma. Invest Ophthalmol Vis Sci. 1993;34:3526–3533. MEDLINE

11. 11 Caprioli J. Correlation of visual function with optic nerve and nerve fiber layer structure in glaucoma. Surv Ophthalmol. 1989;33:319–330.

12. 12 Cello KE, Nelson-Quigg JM, Johnson CA. Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol. 2000;129:314–322. Abstract | Full Text | Full-Text PDF (1416 KB) | CrossRef

13. 13 Chaturvedi N, Hedley-Whyte ET, Dreyer EB. Lateral geniculate nucleus in glaucoma. Am J Ophthalmol. 1993;116:182–188. MEDLINE

14. 14 Chauhan BC, House PH, McCormick TA, LeBlanc RP. Comparison of conventional and high-pass resolution perimetry in a prospective study of patients with glaucoma and healthy controls. Arch Ophthalmol. 1999;117:24–33. MEDLINE

15. 15 Creutzfeldt OD, Lee BB, Elepfandt A. A quantitative study of chromatic organisation and receptive fields of cells in the lateral geniculate body of the rhesus monkey. Exp Brain Res. 1979;35:527–545. MEDLINE

16. 16 Dacey DM: Physiology, morphology and spatial densities of identified ganglion cell types in primate retina. Ciba Found Symp 184:12–28; discussion 28–34, 63–70, 1994

17. 17 Dacey DM. Parallel pathways for spectral coding in primate retina. Annu Rev Neurosci. 2000;23:743–775. CrossRef

18. 18 Dacey DM. Primate retina (cell types, circuits and color opponency). Prog Retin Eye Res. 1999;18:737–763. MEDLINE | CrossRef

19. 19 Dacey DM, Lee BB. The blue-on opponent pathway in primate retina originates from a distinct bistratified ganglion cell type. Nature. 1994;367:731–735. MEDLINE | CrossRef

20. 20 Dacey DM, Petersen MR. Dendritic field size and morphology of midget and parasol ganglion cells of the human retina. Proc Natl Acad Sci USA. 1992;89:9666–9670. MEDLINE | CrossRef

21. 21 Dandona L, Hendrickson A, Quigley HA. Selective effects of experimental glaucoma on axonal transport by retinal ganglion cells to the dorsal lateral geniculate nucleus. Invest Ophthalmol Vis Sci. 1991;32:1593–1599. MEDLINE

22. 22 De Gregorio F, Trani M, Sedran L. Frequency doubling perimetry in early glaucoma diagnosis. Invest Ophthalmol Vis Sci. 1999;40(Suppl):S69; [abstract].

23. 23 De Monasterio FM, Gouras P. Functional properties of ganglion cells of the rhesus monkey retina. J Physiol. 1975;251:167–195. MEDLINE

24. 24 Derrington AM, Lennie P. Spatial and temporal contrast sensitivities of neurones in lateral geniculate nucleus of macaque. J Physiol. 1984;357:219–240. MEDLINE

25. 25 DeYoe EA, Van Essen DC. Concurrent processing streams in monkey visual cortex. Trends Neurosci. 1988;11:219–226. MEDLINE | CrossRef

26. 26 Drance SM. The glaucomatous visual field. Invest Ophthalmol. 1972;11:85–96. MEDLINE

27. 27 Drance SM. The early field defects in glaucoma. Invest Ophthalmol. 1969;8:84–91. MEDLINE

28. 28 Drance SM, Lakowski R, Schulzer M, Douglas GR. Acquired color vision changes in glaucoma. Use of. 1981;100-hue(test and Pickford anomaloscope as predictors of glaucomatous field change. Arch Ophthalmol 99):829–831.

29. 29 Drance SM, Susanna R, Fairclough M: [Early defects in the visual field in glaucoma (authors transl)]. Klin Monatsbl Augenheilkd 173:519–23, 1978

30. 30 Dreher B, Fukada Y, Rodieck RW. Identification, classification and anatomical segregation of cells with X-like and Y-like properties in the lateral geniculate nucleus of old- world primates. J Physiol. 1976;258:433–452. MEDLINE

31. 31 Drum B, Severns M, Oleary D. Selective loss of pattern discrimination in early glaucoma. Applied Optics. 1989;28:1135–1144. CrossRef

32. 32 Drum B, Severns M, Oleary D, et al.  In: Pattern discrimination perimetry and conventional perimetry in early glaucoma detection. Noninvasive Assessment of the Visual System. Washington DC: Optical Society of America; 1988;p. 172–175.

33. 33 Ferrera VP, Nealey TA, Maunsell JH. Responses in macaque visual area V4 following inactivation of the parvocellular and magnocellular LGN pathways. J Neurosci. 1994;14:2080–2088. MEDLINE

34. 34 Ferrera VP, Nealey TA, Maunsell JH. Mixed parvocellular and magnocellular geniculate signals in visual area V4. Nature. 1992;358:756–761. MEDLINE | CrossRef

35. 35 Fitzke FW, Poinoosawmy D, Ernst W, et al: Peripheral displacement thresholds in normals, ocular hypertensive and glaucoma, in Heijl A (ed): Seventh International Visual Field Symposium. Berlin, Springer, 1987, pp 447–52

36. 36 Frisen L. High-pass resolution perimetry (evidence for parvocellular neural channel dependence). Neuro-ophthalmology. 1992;4:257–264.

37. 37 Girkin CA, Emdadi A, Sample PA, et al.  Short-wavelength automated perimetry and standard perimetry in the detection of progressive optic disc cupping. Arch Ophthalmol. 2000;118:1231–1236. MEDLINE

38. 38 Glovinsky Y, Quigley HA, Drum B, et al.  A whole-field scotopic retinal sensitivity test for the detection of early glaucoma damage. Arch Ophthalmol. 1992;110:486–490. MEDLINE

39. 39 Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 1991;32:484–491. MEDLINE

40. 40 Goodale MA, Milner AD. Separate visual pathways for perception and action. Trends Neurosci. 1992;15:20–25. MEDLINE | CrossRef

41. 41 Graham SL, Drance SM, Chauhan BC, et al.  Comparison of psychophysical and electrophysiological testing in early glaucoma. Invest Ophthalmol Vis Sci. 1996;37:2651–2662. MEDLINE

42. 42 Grehn F. The sensitivity of the retinal nerve fibre layer to elevated intraocular pressure and graded hypoxia in the cat. Vision Res. 1981;21:1697–1701. MEDLINE | CrossRef

43. 43 Grehn F, Prost M. Function of retinal nerve fibers depends on perfusion pressure (neurophysiologic investigations during acute intraocular pressure elevation). Invest Ophthalmol Vis Sci. 1983;24:347–353. MEDLINE

44. 44 Harwerth RS, Carter-Dawson L, Shen F, et al.  Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci. 1999;40:2242–2250. MEDLINE

45. 45 Hicks TP, Lee BB, Vidyasagar TR. The responses of cells in macaque lateral geniculate nucleus to sinusoidal gratings. J Physiol. 1983;337:183–200. MEDLINE

46. 46 Joffe KM, Raymond JE, Chrichton A. Motion coherence perimetry in glaucoma and suspected glaucoma. Vision Res. 1997;37:955–964. MEDLINE | CrossRef

47. 47 Johnson CA. Selective versus nonselective losses in glaucoma. J Glaucoma. 1994;3(Suppl):32–44.

48. 48 Johnson CA, Adams AJ, Casson EJ, Brandt JD. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol. 1993;111:645–650. MEDLINE

49. 49 Johnson CA, Cello KE, Nelson-Quigg JM. Performance of frequency doubling perimetry for detecting various levels of glaucomatous field loss. Invest Ophthalmol Vis Sci. 1997;38(Suppl):S200; [abstract].

50. 50 Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 1997;38:413–425. MEDLINE

51. 51 Kanski JJ. In: Clinical Ophthalmology (a systematic approach). London: Butterworths; 1989;p. 181–231.

52. 52 Kaplan E, Shapley RM. The primate retina contains two types of ganglion cells, with high and low contrast sensitivity. Proc Natl Acad Sci USA. 1986;83:2755–2757. MEDLINE | CrossRef

53. 53 Kelly DH. Nonlinear visual responses to flickering sinusoidal gratings. J Opt Soc Am. 1981;71:1051–1055. MEDLINE | CrossRef

54. 54 Kelly DH. Frequency doubling in visual responses. J Opt Soc Am. 1966;56:1628–1633. CrossRef

55. 55 Kolb H, Linberg KA, Fisher SK. Neurons of the human retina (a Golgi study). J Comp Neurol. 1992;318:147–187. MEDLINE | CrossRef

56. 56 Lee BB, Wehrhahn C, Westheimer G, Kremers J. Macaque ganglion cell responses to stimuli that elicit hyperacuity in man (detection of small displacements). J Neurosci. 1993;13:1001–1009. MEDLINE

57. 57 Lee BB, Yeh T. Receptive fields of primate retinal ganglion cells studied with a novel technique. Vis Neurosci. 1998;15:161–175. MEDLINE | CrossRef

58. 58 Leone J, Ochs S. Anoxic block and recovery of axoplasmic transport and electrical excitability of nerve. J Neurobiol. 1978;9:229–245. MEDLINE | CrossRef

59. 59 Livingstone M, Hubel D. Segregation of form, color, movement, and depth (anatomy, physiology, and perception). Science. 1988;240:740–749. MEDLINE

60. 60 Livingstone MS, Hubel DH. Psychophysical evidence for separate channels for the perception of form, color, movement, and depth. J Neurosci. 1987;7:3416–3468. MEDLINE

61. 61 Maddess T, Goldberg I, Dobinson J, et al.  Testing for glaucoma with the spatial frequency doubling illusion. Vision Res. 1999;39:4258–4273. MEDLINE | CrossRef

62. 62 Maddess T, Hemmi JM, James AC. Evidence for spatial aliasing effects in the Y-like cells of the magnocellular visual pathway. Vision Res. 1998;38:1843–1859. MEDLINE | CrossRef

63. 63 Maddess T, Henry GH. Performance of nonlinear visual units in ocular hypertensive and glaucoma. Clin Vision Sci. 1992;7:371–383.

64. 64 Maddess T, James AC, Goldberg I, et al.  Comparing a parallel PERG, automated perimetry, and frequency-doubling thresholds. Invest Ophthalmol Vis Sci. 2000;41:3827–3832. MEDLINE

65. 65 Marrocco RT. Sustained and transient cells in monkey lateral geniculate nucleus (conduction velocites and response properties). J Neurophysiol. 1976;39:340–353. MEDLINE

66. 66 Martin PR, White AJ, Goodchild AK, et al.  Evidence that blue-on cells are part of the third geniculocortical pathway in primates. Eur J Neurosci. 1997;9:1536–1541. CrossRef

67. 67 Martinez GA, Sample PA, Weinreb RN. Comparison of high-pass resolution perimetry and standard automated perimetry in glaucoma. Am J Ophthalmol. 1995;119:195–201. MEDLINE

68. 68 Maunsell JH, Nealey TA, DePriest DD. Magnocellular and parvocellular contributions to responses in the middle temporal visual area (MT) of the macaque monkey. J Neurosci. 1990;10:3323–3334. MEDLINE

69. 69 Merigan WH. Chromatic and achromatic vision of macaques (role of the P pathway). J Neurosci. 1989;9:776–783. MEDLINE

70. 70 Merigan WH, Byrne CE, Maunsell JH. Does primate motion perception depend on the magnocellular pathway?. J Neurosci. 1991;11:3422–3429. MEDLINE

71. 71 Merigan WH, Katz LM, Maunsell JH. The effects of parvocellular lateral geniculate lesions on the acuity and contrast sensitivity of macaque monkeys. J Neurosci. 1991;11:994–1001. MEDLINE

72. 72 Merigan WH, Maunsell JH. How parallel are the primate visual pathways?. Annu Rev Neurosci. 1993;16:369–402.

73. 73 Migdal C. Primary open-angle glaucoma. In:  Tasman W,  Jaeger EA editor. Duane's Clinical Ophthalmology (Diseases of the Retina, Glaucoma, Vol 3). New York: Lippincott-Raven; 1996;p. 1–7.

74. 74 Morgan JE. Selective cell death in glaucoma (does it really occur?). Br J Ophthalmol. 1994;78:875–879 discussion 879–80. MEDLINE | CrossRef

75. 75 Nakayama K, Tyler CW. Psychophysical isolation of movement sensitivity by removal of familiar position cues. Vision Res. 1981;21:427–433. MEDLINE | CrossRef

76. 76 Perez JS, Sample PA, Bosworth CF. Frequency doubling threshold perimetry (FDP) in glaucoma and glaucoma suspect eyes. Invest Ophthalmol Vis Sci. 1998;39(Suppl):S26; [abstract].

77. 77 Perry VH. The ganglion cell layer of the mammalian retina. In:  Osborne N,  Chader G editor. Progress in Retinal Research, Vol I. Oxford: England, Pergamon; 1982;p. 53–80.

78. 78 Perry VH, Oehler R, Cowey A. Retinal ganglion cells that project to the dorsal lateral geniculate nucleus in the macaque monkey. Neuroscience. 1984;12:1101–1123. MEDLINE | CrossRef

79. 79 Purpura K, Kaplan E, Shapley RM. Background light and the contrast gain of primate P and M retinal ganglion cells. Proc Natl Acad Sci USA. 1988;85:4534–4537. MEDLINE | CrossRef

80. 80 Quigley HA. Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology. Am J Ophthalmol. 1998;125:819–829. Abstract | Full Text | Full-Text PDF (601 KB) | CrossRef

81. 81 Quigley HA, Addicks EM. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol. 1981;99:137–143. MEDLINE

82. 82 Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982;100:135–146. MEDLINE

83. 83 Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107:453–464. MEDLINE

84. 84 Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology. 1988;95:357–363. Abstract

85. 85 Quigley HA, Sanchez RM, Dunkelberger GR, et al.  Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci. 1987;28:913–920. MEDLINE

86. 86 Radius RL. Anatomy of the optic nerve head and glaucomatous optic neuropathy. Surv Ophthalmol. 1987;32:35–44. Abstract | Full-Text PDF (1589 KB) | CrossRef

87. 87 Radius RL. Regional specificity in anatomy at the lamina cribrosa. Arch Ophthalmol. 1981;99:478–480. MEDLINE

88. 88 Radius RL, Gonzales M. Anatomy of the lamina cribrosa in human eyes. Arch Ophthalmol. 1981;99:2159–2162. MEDLINE

89. 89 Radius RL, Pederson JE. Laser-induced primate glaucoma II. Histopathology. Arch Ophthalmol. 1984;102:1693–1698.

90. 90 Sample PA, Bosworth CF, Blumenthal EZ, et al.  Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci. 2000;41:1783–1790. MEDLINE

91. 91 Sample PA, Bosworth CF, Weinreb RN. Short-wavelength automated perimetry and motion automated perimetry in patients with glaucoma. Arch Ophthalmol. 1997;115:1129–1133. MEDLINE

92. 92 Sample PA, Weinreb RN. Color perimetry for assessment of primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1990;31:1869–1875. MEDLINE

93. 93 Sample PA, Weinreb RN, Boynton RM. Acquired dyschromatopsia in glaucoma. Surv Ophthalmol. 1986;31:54–64. Abstract | Full-Text PDF (1373 KB) | CrossRef

94. 94 Schiller PH, Logothetis NK, Charles ER. Functions of the colour-opponent and broad-band channels of the visual system. Nature. 1990;343:68–70. MEDLINE | CrossRef

95. 95 Schiller PH, Logothetis NK, Charles ER. Role of the color-opponent and broad-band channels in vision. Vis Neurosci. 1990;5:321–346. MEDLINE | CrossRef

96. 96 Schiller PH, Malpeli JG. Functional specificity of lateral geniculate nucleus laminae of the rhesus monkey. J Neurophysiol. 1978;41:788–797. MEDLINE

97. 97 Shou TD, Zhou YF. Y cells in the cat retina are more tolerant than X cells to brief elevation of IOP. Invest Ophthalmol Vis Sci. 1989;30:2093–2098. MEDLINE

98. 98 Silverman SE, Hart WM, Gordon MO, Kilo C. The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage. Invest Ophthalmol Vis Sci. 1990;31:1895–1902. MEDLINE

99. 99 Smith EL, Chino YM, Harwerth RS. Retinal inputs to the monkeys lateral geniculate nucleus in experimental glaucoma. Clin Vision Science. 1993;8:113–139.

100. 100 Sponsel WE, Arango S, Trigo Y, Mensah J. Clinical classification of glaucomatous visual field loss by frequency doubling perimetry. Am J Ophthalmol. 1998;125:830–836. Abstract | Full Text | Full-Text PDF (537 KB) | CrossRef

101. 101 Stirling RJ, Pawson P, Brimlow GM, Vernon SA. Patients with ocular hypertension have abnormal point scotopic thresholds in the superior hemifield. Invest Ophthalmol Vis Sci. 1996;37:1608–1617. MEDLINE

102. 102 Trick GL, Steinman SB, Amyot M. Motion perception deficits in glaucomatous optic neuropathy. Vision Res. 1995;35:2225–2233. MEDLINE | CrossRef

103. 103 Tyler CW. Specific deficits of flicker sensitivity in glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 1981;20:204–212. MEDLINE

104. 104 Tyler CW. Observations on spatial-frequency doubling. Perception. 1974;3:81–86. MEDLINE

105. 105 Ungerleider LG, Mishkin M. Two cortical visual systems. In:  Mansfield DJW,  Goodale MS editor. Analysis of Visual Behaviour. Cambridge: MIT Press; 1982;p. 549–586.

106. 106 Van Essen DC, Anderson CH, Felleman DJ. Information processing in the primate visual system (an integrated systems perspective). Science. 1992;255:419–423. MEDLINE

107. 107 Vickers JC, Hof PR, Schumer RA, et al.  Magnocellular and parvocellular visual pathways are both affected in a macaque monkey model of glaucoma. Aust NZ J Ophthalmol. 1997;25:239–243.

108. 108 Vickers JC, Schumer RA, Podos SM. Selective vulnerability of neurochemically coded subpopulations of retinal neurons in a monkey model of glaucoma. Invest Ophthalmol Vis Sci. 1994;35(Suppl):S2083; [abstract].

109. 109 Wall M, Jennisch CS, Munden PM. Motion perimetry identifies nerve fiber bundlelike defects in ocular hypertension. Arch Ophthalmol. 1997;115:26–33. MEDLINE

110. 110 Wall M, Ketoff KM. Random dot motion perimetry in patients with glaucoma and in normal subjects. Am J Ophthalmol. 1995;120:587–596. MEDLINE

111. 111 Watanabe M, Rodieck RW. Parasol and midget ganglion cells of the primate retina. J Comp Neurol. 1989;289:434–454. MEDLINE | CrossRef

112. 112 Yamada ES, Silveira LC, Perry VH. Morphology, dendritic field size, somal size, density, and coverage of M and P retinal ganglion cells of dichromatic Cebus monkeys. Vis Neurosci. 1996;13:1011–1029. MEDLINE | CrossRef

113. 113 Yamada N, Chen PP, Mills RP, et al.  Screening for glaucoma with frequency-doubling technology and Damato campimetry. Arch Ophthalmol. 1999;117:1479–1484. MEDLINE

114. 114 Yucel YH, Zhang Q, Gupta N, et al.  Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol. 2000;118:378–384. MEDLINE

1 Department of Ophthalmology, National University of Singapore, Singapore, Singapore

2 Singapore Eye Research Institute, Singapore, Singapore

3 Image Processing and Application Laboratory, CNRS, Singapore, Singapore

Corresponding Author InformationReprint address: Dr Noor Shabana, SERI/Singapore National Eye Centre, 11, Third Hospital Avenue, Singapore 168751, Singapore

PII: S0039-6257(02)00401-0


View previous. 7 of 9 View next.